Our cancer risk assessment test offerings include an array of tests used to identify risk of developing a hereditary cancer or passing it on to offspring. We also offer screening tests for cervical cancer.
Hereditary Cancer Risk Assessment
Testing for hereditary cancer can help identify women who are at risk for a familial cancer syndrome and improve their medical management. It can also inform risk reduction strategies that promote long-term health.
Have questions about hereditary cancer testing? Our genetic counselors are available to guide you through the test selection, coordination, and reporting processes, as well as help you understand the clinical significance of any variants identified by our tests.
For educational content about laboratory testing in hereditary cancer, visit the ARUP Consult Hereditary Cancer Genetic Testing - Germline Testing for Inherited Cancer Syndromes topic.
Hereditary Breast and Ovarian Cancer
Many cases of breast and ovarian cancer are associated with a hereditary cause. Genetic testing for risk assessment can inform diagnosis and treatment, which may improve patient outcomes.
|Test Number||Test Name|
|2012026||Hereditary Breast and Ovarian Cancer Panel, Sequencing and Deletion/Duplication|
|3001855||BRCA1 and BRCA2-Associated HBOC Syndrome Panel, Sequencing and Deletion/Duplication|
|3005632||Hereditary Breast Cancer High-Risk Panel, Sequencing and Deletion/Duplication|
|3005654||Hereditary Breast Cancer Guidelines-Based Panel, Sequencing and Deletion/Duplication|
Hereditary Gastrointestinal Cancer
Hereditary gastrointestinal cancers (e.g., Lynch syndrome) are major causes of cancer-related death in women. Laboratory testing can be used to assess the risk of developing a hereditary cancer or passing it on to offspring, thereby informing patient care. The ARUP Consult Lynch Syndrome - Hereditary Nonpolyposis Colorectal Cancer topic offers a summary of laboratory testing recommendations.